Home Analyst Ratings Piper Sandler lowers Rapid7 Inc. rating to Neutral and sets price...

Piper Sandler lowers Rapid7 Inc. [RPD] rating to Neutral and sets price target at $95

Piper Sandler took its Rapid7 [RPD] rating to the equivalent of Neutral from Overweight, and the price ‎target to 95.0, in a research note dated 2021-01-05. That figure represents around a 5.81% premium ‎from where the company’s shares closed on Monday. Other analysts also revised their coverage, with ‎Monness Crespi & Hardt’s analysts reiterating the shares to “a Buy” rating in a research note to ‎investors issued in early August. Meanwhile, Monness Crespi & Hardt had maintained its rating on RPD ‎to the earlier “Buy” rating, in a research note produced for clients April 29, 2020. In addition, Goldman ‎launched coverage on March 25, 2020. The research firm rated RPD “a Buy”.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Is Rapid7 Inc. [NASDAQ:RPD] a Good Buy Right ‎Now?

It should be noted that RPD technical indicators for short, intermediate as well as long ‎term progress have placed an overall average of 100% as Buy. The average signal changed from 100% ‎Buy in the last week and compares with 100% Buy in the past month. Data from Rapid7 Inc.’s Trend ‎Spotter indicated that the signals were Weakest. The stock current average is 0.72 million shares in the ‎past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average ‎trading volume was 0.62 million shares while the medium term average advocated for 100% Buy. The ‎average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.59 million ‎shares.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


RPD Price Performance

On Wall Street, Rapid7 Inc. [NASDAQ:RPD] finished ‎Monday’s session down -0.42% at $89.78. The stock went up to $91.00 at the same session while its ‎lowest single day price was $86.94. In the last five days, it saw a rise of about 0.56%, Rapid7 Inc. shares ‎dropped by almost -0.42% since the beginning of the year. However, the share price has dropped to as ‎low as -5.09% below its one year high. On 01/04/21, the company shares recorded $91.00, the highest ‎single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same ‎year at $86.94. The company’s shares have inclined by 52.95% in the past year. The 50-day SMA ‎achieved is $74.16 while the 200-day SMA is $58.71. Volume gained to 0.5 million from 0.3 million in the ‎previous session.

RPD Stock Support And Resistance Levels

On the 24-hour scale, the ‎immediate backing is perceived around 87.48 level, and in case of violation of this particular level, it will ‎cause more drop to 85.18 level. On the upper level, 93.30 is still the key resistance. The stock may ‎increase to the subsequent resistance at 91.54. The Relative Strength Index (RSI) pinned on the 14-day ‎chart is 69.12, implying a neutral technical stance while the MACD stands at 4.69, meaning price will ‎increase in the next trading period. Percent R indicator moved to 21.42%, implying bullish price ‎movement. Stochastic %K at 80.13% suggest selling the stock.

What is the short interest in Rapid7 ‎Inc.?

Short interest in the Rapid7 Inc. stock has surged, increasing by 0.39 million shares to total ‎‎5.6 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 5.99 million, ‎data from Yahoo Finance shows. The decrease of -6.96% suggests the stock saw some decreased ‎bullish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account ‎for just 10.93% of the overall float for the stock.

Rapid7 Inc.’s Biggest Shareholders: Who Owns ‎Rapid7 Inc. [RPD]?

Filings by The Vanguard Group, Inc. showed that the firm now holds a total of ‎‎4,133,683 shares or roughly 7.97% of the outstanding RPD shares. This means their shares have ‎reduced by -97,993 from the 4,133,683 the investor reportedly held in its prior 13-F filing. With the ‎conclusion of the sale, Wellington Management Co. LLP updated stake is worth $306,971,027. Details in ‎the latest 13F filings reveal that BlackRock Fund Advisors acquired their 1.40% stake valued at ‎‎$258,063,234 while Fidelity Management & Research Co added theirs at $231,478,644. During the last ‎quarter, BlackRock Fund Advisors raised 47,389 of its shares in Rapid7 Inc. while Fidelity Management ‎& Research Co bought 2,476,829 shares. The Wasatch Advisors, Inc.’s holdings currently number ‎‎1,987,747 shares at $178459925.66. According to the firm’s last 13F report, Federated Global ‎Investment Manag shares in the company at filing stood at 1,736,295 shares, roughly ‎‎$130,117,947.

RPD Earnings Forecast For The Current Quarter

Rapid7 Inc. [RPD] is expected ‎to report weak earnings results for the quarter ending on Dec 2020. Consensus estimates give the ‎company expected revenues of $108.53M and an earnings per share of -$0.08 for Dec 2020. Looking ‎further ahead, the company is expected to report revenue of $111.86M at an EPS of -$0.04 for Mar ‎‎2021. The estimates represent upside of 18.90% and 236.40% in the company’s revenue and earnings ‎per share, respectively, on a year-on-year basis.

Get the hottest stocks to ‎trade every day before the market opens 100% free. Click here ‎now. 

RPD Earnings Estimates For The Current Year

For the ‎financial year, Rapid7 Inc. [NASDAQ:RPD] is expected to bring in revenue of $406.73M. The returns are ‎nearly $79.78 million higher than the company’s actual revenue recorded in the fiscal year 2019. In ‎terms of EPS for the 2020, estimate put it at -0.11, lower than that of FY19 by -$0.2. Estimates put this ‎year’s earnings growth at -222.20%, 236.40% for the next, and at an annual 52.30% over the next 5-‎year period. As for sales, forecasts are for an increase of 24.40% in the current fiscal year and a further ‎‎18.90% over the following year.‎

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam